Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA

PURPOSE: To compare treatment patterns of intravitreal ranibizumab and aflibercept for the management of neovascular age-related macular degeneration (nAMD) in a real-world setting over the first 12 months of treatment. METHODS: A proprietary clinical database was used to identify treatment-naïve pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Alberto, Sagkriotis, Alexandros, Olson, Melvin, Lu, Jingsong, Makin, Charles, Milnes, Fran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514835/
https://www.ncbi.nlm.nih.gov/pubmed/26208030
http://dx.doi.org/10.1371/journal.pone.0133968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514835/
https://www.ncbi.nlm.nih.gov/pubmed/26208030
http://dx.doi.org/10.1371/journal.pone.0133968

Ejemplares similares